Cohort for Monitoring Patients With Venous Thromboembolic Disease

Several tools have been established and validated to help clinicians assess patients' bleeding risk, notably using the HAS BLED, haemorrage, and more recently the VTE BLED score. This latest score, published very recently, is the only one to have been validated in patients treated with direct oral anticoagulants. At the same time, we have recurrence risk scores such as HERDOO2, which allow us to identify patients at low risk of recurrence.

In order to improve the management of patients with venous thromboembolic disease, multidisciplinary thrombosis RCPs have been established since 2015, bringing together hemostasis specialists, internists, oncologists, and private vascular physicians to assist clinicians in managing complex cases. • Dedicated post-emergency consultations twice a week to streamline outpatient care for less serious patients This study aims to evaluate the effectiveness of these tools: score and RCP in the management of patients with venous thromboembolic disease.

Inclusion criteria

• Any patient over 18 years of age who has experienced at least one venous thromboembolic episode:

• Deep vein thrombosis confirmed by Doppler ultrasound or CT venography,
• Pulmonary embolism confirmed by CT angiography, ventilation/perfusion scan, or confirmed DVT episode with respiratory signs consistent with PE.
• Hospitalization in the Internal Medicine Department
• Consultation by an Internal Medicine physician
• File presented at the thrombosis multidisciplinary meeting

Exclusion criteria

Thrombosis not meeting the inclusion criteria (cerebral venous thrombosis, mesenteric)